Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Logo

Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd.

300018.SZ

(1.5)
Stock Price

6,51 CNY

4.54% ROA

5.17% ROE

51.23x PER

Market Cap.

2.913.839.040,00 CNY

0.72% DER

0.74% Yield

13.43% NPM

Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Stock Analysis

Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a low debt to equity ratio (0%), which means it has a small amount of debt compared to the ownership it holds

2 ROE

ROE in an average range (2%) suggests satisfactory profitability and decent utilization of shareholders' equity.

3 ROA

The stock's ROA (1.81%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

4 PBV

The stock's PBV ratio (2.5x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

5 Buffet Intrinsic Value

The company's stock seems undervalued (198) by Warren Buffett's formula, indicating a promising investment opportunity as its intrinsic value exceeds the market price.

6 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

7 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

8 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

9 Graham Number

The Graham number analysis indicates that this company's stock price is likely overpriced, raising concerns about its investment potential.

10 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

11 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Revenue
Year Revenue Growth
2006 76.472.329
2007 115.684.329 33.9%
2008 118.234.771 2.16%
2009 156.925.354 24.66%
2010 129.549.141 -21.13%
2011 178.904.387 27.59%
2012 223.306.832 19.88%
2013 205.221.493 -8.81%
2014 225.106.837 8.83%
2015 270.961.135 16.92%
2016 359.010.984 24.53%
2017 404.040.309 11.14%
2018 376.223.052 -7.39%
2019 393.913.219 4.49%
2020 406.391.731 3.07%
2021 420.509.087 3.36%
2022 442.807.639 5.04%
2023 438.455.865 -0.99%
2023 448.085.402 2.15%
2024 475.299.756 5.73%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Research and Development Expenses
Year Research and Development Expenses Growth
2006 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 9.138.532 100%
2011 18.786.262 51.36%
2012 20.109.058 6.58%
2013 22.269.047 9.7%
2014 29.333.157 24.08%
2015 41.591.973 29.47%
2016 48.503.301 14.25%
2017 51.788.352 6.34%
2018 71.609.673 27.68%
2019 73.540.314 2.63%
2020 79.660.655 7.68%
2021 79.862.236 0.25%
2022 77.905.022 -2.51%
2023 58.716.011 -32.68%
2023 66.217.774 11.33%
2024 53.589.436 -23.56%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. General and Administrative Expenses
Year General and Administrative Expenses Growth
2006 4.728.984
2007 6.244.084 24.26%
2008 9.053.418 31.03%
2009 14.798.366 38.82%
2010 3.546.095 -317.31%
2011 6.259.507 43.35%
2012 7.128.458 12.19%
2013 6.019.011 -18.43%
2014 8.325.595 27.7%
2015 11.409.918 27.03%
2016 11.673.199 2.26%
2017 12.310.639 5.18%
2018 14.790.737 16.77%
2019 12.001.960 -23.24%
2020 12.250.555 2.03%
2021 11.709.004 -4.63%
2022 12.635.755 7.33%
2023 88.425.665 85.71%
2023 9.885.339 -794.51%
2024 -7.816.027 226.48%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. EBITDA
Year EBITDA Growth
2006 34.787.120
2007 52.564.598 33.82%
2008 52.089.022 -0.91%
2009 62.352.366 16.46%
2010 39.363.348 -58.4%
2011 53.965.093 27.06%
2012 66.128.820 18.39%
2013 38.346.241 -72.45%
2014 44.755.757 14.32%
2015 67.315.987 33.51%
2016 120.661.382 44.21%
2017 150.249.242 19.69%
2018 51.668.792 -190.79%
2019 66.140.283 21.88%
2020 94.452.111 29.97%
2021 119.146.296 20.73%
2022 49.491.126 -140.74%
2023 93.966.627 47.33%
2023 100.725.207 6.71%
2024 117.594.320 14.35%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Gross Profit
Year Gross Profit Growth
2006 43.581.167
2007 63.517.885 31.39%
2008 65.937.245 3.67%
2009 85.461.766 22.85%
2010 71.131.112 -20.15%
2011 92.901.531 23.43%
2012 105.628.580 12.05%
2013 96.984.814 -8.91%
2014 121.550.544 20.21%
2015 165.167.943 26.41%
2016 228.104.063 27.59%
2017 236.562.937 3.58%
2018 189.240.629 -25.01%
2019 208.260.124 9.13%
2020 210.213.377 0.93%
2021 201.606.095 -4.27%
2022 204.150.079 1.25%
2023 196.833.447 -3.72%
2023 212.113.568 7.2%
2024 238.395.804 11.02%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Net Profit
Year Net Profit Growth
2006 26.951.498
2007 46.448.313 41.98%
2008 46.563.703 0.25%
2009 57.995.243 19.71%
2010 44.107.856 -31.49%
2011 38.317.381 -15.11%
2012 41.855.416 8.45%
2013 38.636.193 -8.33%
2014 49.859.351 22.51%
2015 75.153.078 33.66%
2016 106.780.191 29.62%
2017 100.098.101 -6.68%
2018 -446.505.022 122.42%
2019 49.400.268 1003.85%
2020 45.794.436 -7.87%
2021 89.609.673 48.9%
2022 8.839.240 -913.77%
2023 67.695.971 86.94%
2023 60.113.292 -12.61%
2024 94.897.252 36.65%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2006 1
2007 1 100%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 -1 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Free Cashflow
Year Free Cashflow Growth
2006 8.025.142
2007 37.376.259 78.53%
2008 18.672.027 -100.17%
2009 52.944.958 64.73%
2010 2.015.581 -2526.78%
2011 -18.826.039 110.71%
2012 4.978.977 478.11%
2013 37.601.688 86.76%
2014 17.203.960 -118.56%
2015 80.533.961 78.64%
2016 106.716.639 24.53%
2017 125.020.341 14.64%
2018 24.107.467 -418.6%
2019 77.510.083 68.9%
2020 27.397.763 -182.91%
2021 23.767.702 -15.27%
2022 31.412.386 24.34%
2023 -582.048 5496.87%
2023 52.093.365 101.12%
2024 14.659.793 -255.35%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Operating Cashflow
Year Operating Cashflow Growth
2006 12.232.478
2007 39.550.138 69.07%
2008 21.002.107 -88.32%
2009 53.428.924 60.69%
2010 19.594.888 -172.67%
2011 14.753.703 -32.81%
2012 21.908.623 32.66%
2013 47.316.265 53.7%
2014 48.494.924 2.43%
2015 101.579.016 52.26%
2016 119.382.643 14.91%
2017 130.914.657 8.81%
2018 41.899.932 -212.45%
2019 88.012.804 52.39%
2020 42.357.987 -107.78%
2021 40.721.419 -4.02%
2022 39.909.130 -2.04%
2023 0 0%
2023 57.928.717 100%
2024 15.310.636 -278.36%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Capital Expenditure
Year Capital Expenditure Growth
2006 4.207.335
2007 2.173.879 -93.54%
2008 2.330.080 6.7%
2009 483.966 -381.46%
2010 17.579.306 97.25%
2011 33.579.742 47.65%
2012 16.929.645 -98.35%
2013 9.714.576 -74.27%
2014 31.290.964 68.95%
2015 21.045.055 -48.69%
2016 12.666.003 -66.15%
2017 5.894.316 -114.89%
2018 17.792.465 66.87%
2019 10.502.721 -69.41%
2020 14.960.223 29.8%
2021 16.953.716 11.76%
2022 8.496.744 -99.53%
2023 582.048 -1359.8%
2023 5.835.352 90.03%
2024 650.843 -796.58%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Equity
Year Equity Growth
2006 24.953.844
2007 40.924.794 39.03%
2008 84.488.498 51.56%
2009 645.286.811 86.91%
2010 656.894.668 1.77%
2011 696.535.717 5.69%
2012 722.023.223 3.53%
2013 741.749.635 2.66%
2014 778.925.061 4.77%
2015 1.379.186.466 43.52%
2016 1.472.549.180 6.34%
2017 1.563.286.891 5.8%
2018 1.060.341.644 -47.43%
2019 1.101.831.440 3.77%
2020 1.150.599.558 4.24%
2021 1.242.540.180 7.4%
2022 1.221.010.375 -1.76%
2023 1.243.422.244 1.8%
2023 1.257.200.001 1.1%
2024 1.271.849.612 1.15%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Assets
Year Assets Growth
2006 63.499.610
2007 107.788.492 41.09%
2008 115.989.387 7.07%
2009 689.145.231 83.17%
2010 692.561.012 0.49%
2011 771.636.056 10.25%
2012 811.779.863 4.95%
2013 812.611.910 0.1%
2014 854.109.663 4.86%
2015 1.522.707.260 43.91%
2016 1.598.126.722 4.72%
2017 1.740.886.964 8.2%
2018 1.211.329.456 -43.72%
2019 1.243.785.602 2.61%
2020 1.322.615.923 5.96%
2021 1.420.920.283 6.92%
2022 1.387.956.265 -2.38%
2023 1.382.756.205 -0.38%
2023 1.438.684.571 3.89%
2024 1.427.612.005 -0.78%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Liabilities
Year Liabilities Growth
2006 38.545.765
2007 66.863.698 42.35%
2008 31.500.889 -112.26%
2009 43.858.419 28.18%
2010 35.666.344 -22.97%
2011 75.100.338 52.51%
2012 89.756.640 16.33%
2013 70.862.274 -26.66%
2014 75.184.601 5.75%
2015 143.520.793 47.61%
2016 125.577.542 -14.29%
2017 177.600.071 29.29%
2018 150.987.811 -17.63%
2019 141.954.161 -6.36%
2020 172.016.364 17.48%
2021 178.380.102 3.57%
2022 166.945.889 -6.85%
2023 139.333.961 -19.82%
2023 181.484.569 23.23%
2024 155.762.392 -16.51%

Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.98
Net Income per Share
0.13
Price to Earning Ratio
51.23x
Price To Sales Ratio
6.16x
POCF Ratio
19.11
PFCF Ratio
17.36
Price to Book Ratio
2.63
EV to Sales
5.38
EV Over EBITDA
25.9
EV to Operating CashFlow
14.93
EV to FreeCashFlow
15.16
Earnings Yield
0.02
FreeCashFlow Yield
0.06
Market Cap
2,91 Bil.
Enterprise Value
2,54 Bil.
Graham Number
2.77
Graham NetNet
1.31

Income Statement Metrics

Net Income per Share
0.13
Income Quality
2.68
ROE
0.05
Return On Assets
0.04
Return On Capital Employed
0.06
Net Income per EBT
0.75
EBT Per Ebit
1.12
Ebit per Revenue
0.16
Effective Tax Rate
0.19

Margins

Sales, General, & Administrative to Revenue
0.02
Research & Developement to Revenue
0.13
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.46
Operating Profit Margin
0.16
Pretax Profit Margin
0.18
Net Profit Margin
0.13

Dividends

Dividend Yield
0.01
Dividend Yield %
0.74
Payout Ratio
0.39
Dividend Per Share
0.05

Operating Metrics

Operating Cashflow per Share
0.35
Free CashFlow per Share
0.35
Capex to Operating CashFlow
0.01
Capex to Revenue
0.01
Capex to Depreciation
0.25
Return on Invested Capital
0.05
Return on Tangible Assets
0.05
Days Sales Outstanding
141.65
Days Payables Outstanding
88.57
Days of Inventory on Hand
208.03
Receivables Turnover
2.58
Payables Turnover
4.12
Inventory Turnover
1.75
Capex per Share
0.01

Balance Sheet

Cash per Share
1,19
Book Value per Share
2,65
Tangible Book Value per Share
2.59
Shareholders Equity per Share
2.58
Interest Debt per Share
0.02
Debt to Equity
0.01
Debt to Assets
0.01
Net Debt to EBITDA
-3.76
Current Ratio
6
Tangible Asset Value
1,24 Bil.
Net Current Asset Value
0,75 Bil.
Invested Capital
823701490
Working Capital
0,76 Bil.
Intangibles to Total Assets
0.02
Average Receivables
0,18 Bil.
Average Payables
0,06 Bil.
Average Inventory
137395980
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Dividends
Year Dividends Growth
2010 0
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2023 0 0%
2024 0 0%

Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Profile

About Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd.

Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. engages in the smart grid and healthcare business in China. It is involved in research and development, manufacturing, sales, and service of products related to intelligent recording and analysis of power systems, time synchronization, substation integrated automation, and distribution network automation. The company offers power fault recording devices, time synchronization devices, substation integrated automation devices, intelligent distribution network equipment, smart grid testing instruments, etc., as well as medical informatization and in-vitro diagnosis related products. Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. was founded in 2001 and is based in Wuhan, China.

CEO
Mr. WeiBing Huang
Employee
732
Address
Huazhong Univ of Science & Tech Park
Wuhan, 43 0223

Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Executives & BODs

Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Executives & BODs
# Name Age
1 Mr. WeiBing Huang
Chief Financial Officer & Board Secretary
70
2 Ms. Jinmei Xiong
Vice President
70

Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Competitors